<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">121481</article-id><article-id pub-id-type="doi">10.23868/gc121481</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The effect of mesenchymal stromal cells and the mobilization of stem cells in bone marrow on the development of nephrosclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние мезенхималыных стромалыных клеток и мобилизации стволовых клеток костного мозга на развитие нефросклероза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Belogorodtsev</surname><given-names>S N</given-names></name><name xml:lang="ru"><surname>Белогородцев</surname><given-names>С Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>Учреждение РАМН НИИ Клинической иммунологии СО РАМН, Новосибирск г ГУ НИИ Терапии СО РАМН, Новосибирск</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shvarts</surname><given-names>Ya Sh</given-names></name><name xml:lang="ru"><surname>Шварц</surname><given-names>Я Ш</given-names></name></name-alternatives><bio xml:lang="ru"><p>ГУ НИИ Терапии СО РАМН, Новосибирск</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Filimonov</surname><given-names>P N</given-names></name><name xml:lang="ru"><surname>Филимонов</surname><given-names>П Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>ФГУ Новосибирский НИИ Туберкулеза МЗСР РФ, Новосибирск</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Seledtsova</surname><given-names>G V</given-names></name><name xml:lang="ru"><surname>Селедцова</surname><given-names>Г В</given-names></name></name-alternatives><bio xml:lang="ru"><p>Учреждение РАМН НИИ Клинической иммунологии СО РАМН, Новосибирск г ГУ НИИ Терапии СО РАМН, Новосибирск</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Belogorodtsev</surname><given-names>S N</given-names></name><bio xml:lang="en"><p>State Research Institute of Clinical Immunology Siberian Branch of RAMS, Novosibirsk</p></bio><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name><surname>Schvarz</surname><given-names>Ya S</given-names></name><bio xml:lang="en"><p>State Scientific-Research Institute of Therapy Siberian Branch of RAMS, Novosibirsk</p></bio><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><name><surname>Filimonov</surname><given-names>P N</given-names></name><bio xml:lang="en"><p>Novosibirsk Research Institute of Tuberculosis, Novosibirsk</p></bio><xref ref-type="aff" rid="aff6"/></contrib><contrib contrib-type="author"><name><surname>Seledtsova</surname><given-names>G V</given-names></name><bio xml:lang="en"><p>State Research Institute of Clinical Immunology Siberian Branch of RAMS, Novosibirsk</p></bio><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Учреждение РАМН НИИ Клинической иммунологии СО РАМН, Новосибирск г ГУ НИИ Терапии СО РАМН, Новосибирск</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ГУ НИИ Терапии СО РАМН, Новосибирск</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ФГУ Новосибирский НИИ Туберкулеза МЗСР РФ, Новосибирск</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">State Research Institute of Clinical Immunology Siberian Branch of RAMS, Novosibirsk</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">State Scientific-Research Institute of Therapy Siberian Branch of RAMS, Novosibirsk</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">Novosibirsk Research Institute of Tuberculosis, Novosibirsk</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2010-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2010</year></pub-date><volume>5</volume><issue>2</issue><issue-title xml:lang="en">NO2 (2010)</issue-title><issue-title xml:lang="ru">№2 (2010)</issue-title><fpage>68</fpage><lpage>72</lpage><history><date date-type="received" iso-8601-date="2023-01-11"><day>11</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2010, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2010, Эко-Вектор</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/121481">https://genescells.ru/2313-1829/article/view/121481</self-uri><abstract xml:lang="en"><p>The effects of autologous mesenchymal stromal cell CMSC) transplantation and of bone marrow IBM) hematopoietic cells mobilization on the course of rhabdomyolysis-induced nephropathy in mice were studied. Both MSC transplantation and mobilization of hematopoietic BM cells were demonstrated to improve function and to inhibit fibrotic transformation of the kidney. At the same time MSC transplantation had no impact on the levels of mononuclear infiltration and on the casts formation, but decreased systemic proinflammatory responsiveness. Mobilization of BM hematopoietic cells, on the contrary, enhanced the levels of mononuclear infiltration and casts formation in renal tissue, but did not alter the systemic proinflammatory responsiveness. Both MSC transplantation and BM hematopoietic cells mobilization were concluded to be the most promising approaches to the development of novel therapeutic methods to treat progressive nephropathy.</p></abstract><trans-abstract xml:lang="ru"><p>В экспериментах на мышах в модели хронического рабдо-миолизного поражения почек исследовалось влияние трансплантации сингенных мультипатентных мезенхимальных стро-мальных клеток (ММСЮ и мобилизации гемопоэтических клеток костного мозга (КМ) на течение нефропатии. Показано, что оба этих воздействия улучшают экскреторную функцию почек и препятствуют фибросклеротической трансформации почечной ткани. В то же время, трансплантация ММСК практически не влияет на выраженность мононуклеарной инфильтрации почек и на цилиндрообразование, но супрессирует системные провоспалительные реакции. Мобилизация КМ значительно увеличивает моноцитарную инфильтрацию и образование цилиндров, но практически не влияет на провоспа-лительную реактивность иммунной системы. Сделан вывод о высокой перспективности обоих подходов для разработки новых методов лечения хронических прогрессивных нефропатии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>nehprosclerosis</kwd><kwd>mesenchymal stromal cell</kwd><kwd>hematopoietic cell mobilization</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нефросклероз</kwd><kwd>мезенхималычые строгальные клетки</kwd><kwd>мобилизация костного мозга</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Chatziantoniou С, Dussaule J-C. Insight into the mechanisms of renal fibrosis: is it possible to achieve regression? Am. J. Physiol. Renal. Physiol. 20D5; 289: 227-34.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Yu H.T. Progression ofchronic renal failure. Arch. Intern. Med. 2003; 1B3: 1417-29.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>KisselevaT., Brenner D.A. Mechanisms of fibrogenesis. Exp. Biol. Med. 2008; 233: 109-22.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Boor P., Sebekova K., Ostendorf Т., Floege J. Treatment target in renal fibrosis. Nephrol. Dial. Transplant. 2007; 22: 3391-407.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Parmar M.S. Chronic renal disease. BMJ 2002; 325:85-90.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Togel F., Hu Z., Weis K. et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal. Physiol. 2005; 289: 31-42.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Morigi M., Imberti В., Zola С et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 2004; 15: 1794-804.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Bi В., Schmitt R., Israilova H. et al. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 2007; 18: 2486-96.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Togel F., Weiss K., Yang Y. et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal. Physiol. 2007; 292: 1626-35.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Morigi M., Introna M., Imberti B. et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26: 2075-82.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>H.Herrera M.B., Bussolati В., Bruno S. et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney International 2007; 72: 430-41.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Poulson R., Alison M.A., Cook T. et al. Bone marrow stem cells contribute to healing of the kidney. J. Am. Soc. Nephrol. 2003; 14: 48-54.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Guo J-K., Schedl A., Krause D.S. Bone marrow transplantation can attenuate the progression of mesangial sclerosis. Stem Cells 2006; 24: 406-15.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Burne-Taney M.J., Kofler J., Yokota N. et al. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am. J. Physiol. Renal. Physiol. 2003; 285: 87-94.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Rabb H. Immune modulation of acute kidney injury. J. Am. Soc. Nephrol. 2006; 17: 604-6.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Jo S-K., Sung S-A., Cho W-Y. et al. Macrophages contribute to the initiation of ischemic acute renal failure in rats. Nephrol. Dial. Transplant. 2006; 21: 1231-9.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Zager R.A., Johnson A.C.M., Lung S. et al. Acute renal failure: determinants and characteristics of the injury-induced hyperinf lammatory response. Am. J. Physiol. Renal. Physiol. 2006; 291: 546-56.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Catania J.M., Chen G., Parrish A.R. Role of metalloproteinases in renal pathophisiologies. Am. J. Physiol. Renal. Physiol. 2007; 292: 905-11.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal sells. Blood 2007; 110: 3499-506.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Кругляков П.В., Лохматова Е.А., Климович В.В., Зарицкий А.Ю. Мезенхимальные стволовые клетки и иммунопатологические состояния организма. Клеточная трансплантология и тканевая инженерия 2008; 3(5): 36-41.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Iwasaki М., Adachi Y., Minamino К. et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-indused renal failure, and M-CSF enhances the effect of G-CSF.J. Am. Soc. Nephrol. 2005: 16: 658-66.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Togel F., Isaac J., Westenfelder С Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure. J. Am. Soc. Nephrol. 2004; 15: 1261-7.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Stokman G., Leemans J.C., Claessen N., Weening J.J., Florquin S. Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J. Am. Soc. Nephrol. 2005; 16: 1684-92.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Kurtz T.W., Maletz R.M., Hsu C.H. Renal cortical blood flow in glycerol-induced acute renal failure in the rat. Circ. Res. 1976; 38: 30-35.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Lieberthal W., Nigam S.K. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am. J. Physiol. Renal Physiol. 2000; 278: 1-12.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Zager R.A., Jonson A.C., Lund S. et al. Acute renal failure: determinants and characteristics of injury-induced hyperinflammatory response. Am. J. Physiol. Renal Physiol. 2006; 291: 546-56.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Шестобаев Е.Ю., Капля О.А., Зуева Е.П., Разина Т.Г. Функциональная активность перитонеальных макрофагов при развитии карциномы легких Льюс на фоне применения экстракта шлемника байкальского и циклофосфана. Сибирский онкологический журнал 2004; 4: 37-41.</mixed-citation></ref></ref-list></back></article>
